Skip to main content
. 2019 Feb 27;17(2):e05598. doi: 10.2903/j.efsa.2019.5598

Figure 60.

Figure 60

Trends in ciprofloxacin (CIP), erythromycin (ERY), gentamicin (GEN), nalidixic acid (NAL), streptomycin (STR) and tetracycline (TET) resistance in Campylobacter coli isolates from pigs, 3 reporting countries, 2008–2017

  • Statistically significance of trends over 4/5 or more years was tested by a logistic regression model (p ≤ 0.05).
  • Statistically significant increasing trends were observed for ciprofloxacin, nalidixic acid, streptomycin and tetracycline in Switzerland.
  • Statistically significant decreasing trends were observed for erythromycin in the Netherlands, Spain and Switzerland, for gentamicin in Spain, for streptomycin in Spain.